3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
71
Neoplasms
70
Lung Neoplasms
29
Prostatic Neoplasms
26
Head and Neck Neoplasms
22
Colorectal Neoplasms
19
Uterine Cervical Neoplasms
17
Ovarian Neoplasms
13
Neoplasm Metastasis
13
Motor Activity
13
Fatigue
11
Endometrial Neoplasms
11
Colonic Neoplasms
11
Brain Neoplasms
11
Pain
10
Carcinoma, Non-Small-Cell Lung
10
Multiple Myeloma
9
Melanoma
9
Rectal Neoplasms
8
Leukemia
8
Gastrointestinal Neoplasms
8
Smoking Cessation
7
Pancreatic Neoplasms
7
Lymphoma
7
Depression
7
cyclopia sequence
6
Esophageal Neoplasms
6
Carcinoma, Renal Cell
6
Advanced Cancer
6
Uterine Neoplasms
5
Interventions
pembrolizumab
3
Ipilimumab
2
Blood Specimen Collection
2
spartalizumab
1
necitumumab
1
mirdametinib
1
leronlimab
1
apatinib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Jupiter
1
JPT1 protein, human
1
Interleukin-2
1
Immune Checkpoint Inhibitors
1
GAT
1
Fluorodeoxyglucose F18
1
FCN-437c
1
EBI-005
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Tumor, Adult
×
Surveys and Questionnaires
×
Clear all
NCT04310033
2021-09-01
QdV-ONCOREA
University Hospital, Grenoble
Completed
60 enrolled